[
    [
        {
            "time": "2018-12-31",
            "original_text": "大参林(603233.SH)2018年度净利润升11.93%至5.32亿元 拟10转3派6",
            "features": {
                "keywords": [
                    "大参林",
                    "2018年度",
                    "净利润",
                    "增长",
                    "11.93%",
                    "分红",
                    "10转3派6"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大参林(603233.SH)2018年度净利润升11.93%至5.32亿元 拟10转3派6",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-31",
            "original_text": "大参林2018年度关联交易执行情况及2019年度日常关联交易预计的公告",
            "features": {
                "keywords": [
                    "大参林",
                    "关联交易",
                    "2018年度",
                    "2019年度",
                    "预计"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "大参林2018年度关联交易执行情况及2019年度日常关联交易预计的公告",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-12-31",
            "original_text": "大参林：为子公司申请银行授信额度提供不超过1亿元担保 大额借贷担保",
            "features": {
                "keywords": [
                    "大参林",
                    "子公司",
                    "银行授信",
                    "担保",
                    "1亿元"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "大参林：为子公司申请银行授信额度提供不超过1亿元担保 大额借贷担保",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-12-31",
            "original_text": "大参林：2018年净利润同比增11.93%",
            "features": {
                "keywords": [
                    "大参林",
                    "2018年",
                    "净利润",
                    "同比增长",
                    "11.93%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "大参林：2018年净利润同比增11.93%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]